These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 37680268)

  • 1. Willingness of people living with HIV to receive a second COVID-19 booster dose: a multicenter cross-sectional study in China.
    Lan X; Su B; Liang S; Yu M; Qiao Y; Wang L; Song M; Wang Y; Xu J
    Front Public Health; 2023; 11():1227277. PubMed ID: 37680268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China.
    Wu S; Ming F; Xing Z; Zhang Z; Zhu S; Guo W; Zou S; Liu J; Liu Y; Liang K
    Front Public Health; 2022; 10():883453. PubMed ID: 35615040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to receive the COVID-19 vaccine among HIV positive men who have sex with men in China: a cross-sectional study.
    Wu S; Zhu S; Yan X; Xu Y; Xu H; Yang F; Han Z; Gu Y; Zhou Y; Yang Z; Yang H; Shu B; Tang W; Liang K
    BMC Public Health; 2023 Jan; 23(1):64. PubMed ID: 36627582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey.
    Huang X; Yu M; Fu G; Lan G; Li L; Yang J; Qiao Y; Zhao J; Qian HZ; Zhang X; Liu X; Jin X; Chen G; Jiang H; Tang W; Wang Z; Xu J
    JMIR Public Health Surveill; 2021 Oct; 7(10):e31125. PubMed ID: 34543223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey.
    Su J; Jia Z; Wang X; Qin F; Chen R; Wu Y; Lu B; Lan C; Qin T; Liao Y; Shi M; Liao Y; Pan P; Ye L; Jiang J; Liang H
    BMC Infect Dis; 2022 May; 22(1):471. PubMed ID: 35578187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are people living with HIV have a low vulnerability to omicron variant infection: results from a cross-sectional study in China.
    Tan Y; Wu S; Guo W; Liu J; Ming F; Zou S; Tang W; Liang K; Yang J
    BMC Infect Dis; 2023 Nov; 23(1):795. PubMed ID: 37964230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study.
    Qin C; Yan W; Du M; Liu Q; Tao L; Liu M; Liu J
    Front Public Health; 2022; 10():986916. PubMed ID: 36589991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection, Hospitalization, and Associated Factors Among People Living With HIV in Southeastern China From December 2022 to February 2023: Cross-Sectional Survey.
    Cheng W; Xu Y; Jiang H; Li J; Hou Z; Meng H; Wang W; Chai C; Jiang J
    JMIR Public Health Surveill; 2024 Apr; 10():e51449. PubMed ID: 38630534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: A cross-sectional study in Puyang city, China.
    Zhou Y; Li GX; Zhao TS; Du J; Zhang WX; Xie MZ; Chen LY; Zeng J; Wang C; Liu B; Liu YQ; Cui F; Lu QB
    J Med Virol; 2023 Jan; 95(1):e28256. PubMed ID: 36305477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccination willingness among people living with HIV in Shijiazhuang, China: a cross-sectional survey.
    Zhang X; Zhan H; Wang L; Liu Y; Guo X; Li C; Li X; Li B; Li H; Li Y; Chen Q; Gao H; Feng F; Li Y; Dai E
    Front Med (Lausanne); 2024; 11():1322440. PubMed ID: 38314204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Psychological Experience of COVID-19 Vaccination and Its Impact on the Willingness to Receive Booster Vaccines among the Chinese Population: Evidence from a National Cross-Sectional Study.
    Miao Y; Li Y; Zhang W; Wu J; Gu J; Wang M; Wei W; Ye B; Miao C; Tarimo CS; Dong W
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tale of two conditions: when people living with HIV meet three doses of inactivated COVID-19 vaccines.
    Tan Y; Zou S; Ming F; Wu S; Guo W; Wu M; Tang W; Liang K
    Front Immunol; 2023; 14():1174379. PubMed ID: 37404815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Willingness to receive a booster dose of inactivated coronavirus disease 2019 vaccine in Taizhou, China.
    Tung TH; Lin XQ; Chen Y; Zhang MX; Zhu JS
    Expert Rev Vaccines; 2022 Feb; 21(2):261-267. PubMed ID: 34894991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to receive the second booster of COVID-19 vaccine among older adults with cancer: a stratified analysis in four provinces of China.
    Zhang L; Yang J; Su R; Lan X; Song M; Zhang L; Xu J
    Front Public Health; 2024; 12():1298070. PubMed ID: 38454989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with COVID-19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: a cross-sectional study.
    Allen K; Lambert SB; Yuen A; Pourmarzi D
    BMC Public Health; 2022 Nov; 22(1):2205. PubMed ID: 36443806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy.
    Della Polla G; Miraglia Del Giudice G; Folcarelli L; Napoli A; Angelillo IF;
    Front Public Health; 2022; 10():1051035. PubMed ID: 36568799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. People living with HIV with the Omicron variant infection have milder COVID-19 symptoms: results from a cross-sectional study.
    Tan Y; Wu S; Ming F; Liu J; Marley G; Yu A; Luo Y; Zou S; Guo W; Tang W; Liang K
    AIDS Res Ther; 2024 Aug; 21(1):53. PubMed ID: 39127636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study).
    Kling KD; Janulis P; Demonbreun AR; Sancilio A; Berzins B; Krueger K; Achenbach C; Price R; Sullivan M; Caputo M; Hockney S; Zembower T; McDade TW; Taiwo B
    Front Immunol; 2022; 13():1048776. PubMed ID: 36700200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptance of COVID-19 boosters among hypertensive patients in China: A multicenter cross-sectional study.
    Yan Y; Chen Q; Nuermaimaiti A; Xiao Y; Chang L; Ji H; Sun H; Song Q; Gao Y; Xu J; Wang L
    Hum Vaccin Immunother; 2023 Dec; 19(3):2283315. PubMed ID: 37982140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study.
    Lu T; Chen Z; Cao Y; Ao L; Li Z; Gu X; Ren X; Wang Y; Zhang G; Xiang D; Chen M; Cai D; Hu P; Zhang D; Peng M; Shi X; Ren H
    J Med Virol; 2023 Apr; 95(4):e28730. PubMed ID: 37185852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.